Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity. (2nd May 2021)
- Record Type:
- Journal Article
- Title:
- Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity. (2nd May 2021)
- Main Title:
- Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity
- Authors:
- Wang, Jing
Ge, Pupu
Lei, Zehui
Lu, Zhe
Qiang, Lihua
Chai, Qiyao
Zhang, Yong
Zhao, Dongdong
Li, Bingxi
Su, Jiaqi
Peng, Ruchao
Pang, Yu
Shi, Yi
Zhang, Yu
Gao, George Fu
Qiu, Xiao‐Bo
Liu, Cui Hua - Abstract:
- Abstract: Upon Mycobacterium tuberculosis (Mtb) infection, protein kinase G (PknG), a eukaryotic‐type serine‐threonine protein kinase (STPK), is secreted into host macrophages to promote intracellular survival of the pathogen. However, the mechanisms underlying this PknG–host interaction remain unclear. Here, we demonstrate that PknG serves both as a ubiquitin‐activating enzyme (E1) and a ubiquitin ligase (E3) to trigger the ubiquitination and degradation of tumor necrosis factor receptor‐associated factor 2 (TRAF2) and TGF‐β‐activated kinase 1 (TAK1), thereby inhibiting the activation of NF‐κB signaling and host innate responses. PknG promotes the attachment of ubiquitin (Ub) to the ubiquitin‐conjugating enzyme (E2) UbcH7 via an isopeptide bond (UbcH7 K82‐Ub), rather than the usual C86‐Ub thiol‐ester bond. PknG induces the discharge of Ub from UbcH7 by acting as an isopeptidase, before attaching Ub to its substrates. These results demonstrate that PknG acts as an unusual ubiquitinating enzyme to remove key components of the innate immunity system, thus providing a potential target for tuberculosis treatment. SYNOPSIS: The Mycobaterium tuberculosis effector protein PknG acts as an unusual ubiquitinating enzyme to promote the polyubiquitination and degradation of its substrates TRAF2 and TAK1 via a two‐step cascade, thereby suppressing host innate immune responses. PknG acts as an unconventional E1 enzyme to catalyze covalent ubiquitin conjugation to UbcH7. PknG functions asAbstract: Upon Mycobacterium tuberculosis (Mtb) infection, protein kinase G (PknG), a eukaryotic‐type serine‐threonine protein kinase (STPK), is secreted into host macrophages to promote intracellular survival of the pathogen. However, the mechanisms underlying this PknG–host interaction remain unclear. Here, we demonstrate that PknG serves both as a ubiquitin‐activating enzyme (E1) and a ubiquitin ligase (E3) to trigger the ubiquitination and degradation of tumor necrosis factor receptor‐associated factor 2 (TRAF2) and TGF‐β‐activated kinase 1 (TAK1), thereby inhibiting the activation of NF‐κB signaling and host innate responses. PknG promotes the attachment of ubiquitin (Ub) to the ubiquitin‐conjugating enzyme (E2) UbcH7 via an isopeptide bond (UbcH7 K82‐Ub), rather than the usual C86‐Ub thiol‐ester bond. PknG induces the discharge of Ub from UbcH7 by acting as an isopeptidase, before attaching Ub to its substrates. These results demonstrate that PknG acts as an unusual ubiquitinating enzyme to remove key components of the innate immunity system, thus providing a potential target for tuberculosis treatment. SYNOPSIS: The Mycobaterium tuberculosis effector protein PknG acts as an unusual ubiquitinating enzyme to promote the polyubiquitination and degradation of its substrates TRAF2 and TAK1 via a two‐step cascade, thereby suppressing host innate immune responses. PknG acts as an unconventional E1 enzyme to catalyze covalent ubiquitin conjugation to UbcH7. PknG functions as an isopeptidase to release ubiquitin from the E2 enzyme UbcH7. PknG promotes substrate polyubiquitination depending on its E3 ligase activity. Abstract : The Mycobaterium tuberculosis effector protein PknG acts as an unusual ubiquitinating enzyme to promote the polyubiquitination and degradation of its substrates TRAF2 and TAK1 via a two‐step cascade, thereby suppressing host innate immune responses. … (more)
- Is Part Of:
- EMBO reports. Volume 22:Number 6(2021)
- Journal:
- EMBO reports
- Issue:
- Volume 22:Number 6(2021)
- Issue Display:
- Volume 22, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 22
- Issue:
- 6
- Issue Sort Value:
- 2021-0022-0006-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-05-02
- Subjects:
- Mycobacterium tuberculosis -- NF‐κB signaling -- protein kinase G -- ubiquitin ligase -- ubiquitin‐activating enzyme
Molecular biology -- Periodicals
Molecular Biology -- Periodicals
Molecular biology
Periodicals
572.8 - Journal URLs:
- http://www.embo-reports.oupjournals.org/ ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1469-221x;screen=info;ECOIP ↗ - DOI:
- 10.15252/embr.202052175 ↗
- Languages:
- English
- ISSNs:
- 1469-221X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3733.086000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23488.xml